Catalio Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.67M Buy
162,596
+47,980
+42% +$2.26M 1.61% 20
2025
Q1
$4.48M Buy
+114,616
New +$4.48M 1.09% 21